SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome model.

Connelly, S; Bristol, J A; Hubert, S; Subramanian, P; Hasan, N A; Colwell, R R; Kaleko, M

Connelly, S; Bristol, J A; Hubert, S; Subramanian, P; Hasan, N A; Colwell, R R; Kaleko, M.

Afiliación

Connelly S; Synthetic Biologics Inc., Rockville, MD, USA.
Bristol JA; Synthetic Biologics Inc., Rockville, MD, USA.
Hubert S; Synthetic Biologics Inc., Rockville, MD, USA.
Subramanian P; CosmosID Inc., Rockville, MD, USA.
Hasan NA; CosmosID Inc., Rockville, MD, USA.
Colwell RR; University of Maryland Institute of Advanced Computer Studies, University of Maryland, College Park, MD, USA.
Kaleko M; CosmosID Inc., Rockville, MD, USA.

J Appl Microbiol ; 123(1): 66-79, 2017 Jul.

Article en En | MEDLINE | ID: mdl-28245091

Palabras clave

antibiotic; antibiotic resistance; beta-lactamase; dysbiosis; intestinal microbiology; microbiome; pig

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Appl Microbiol Asunto de la revista: MICROBIOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google